1 option
Clinical review report Emtricitabine/tenofovir alafenamide fumarate (Descovy) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Language:
- English
- Subjects (All):
- HIV infections--Treatment.
- HIV infections.
- Physical Description:
- 1 online resource (1 PDF file (xiii, 69 pages)) : illustrations
- Other Title:
- Clinical review report Emtricitabine/tenofovir alafenamide fumarate
- Place of Publication:
- Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health, 2016.
- Summary:
- The objective of this systematic review was to evaluate of the beneficial and harmful effects of the fixed-dose combination of emtricitabine/tenofovir alafenamide fumarate in combination with other antiretrovirals for the treatment of human immunodeficiency virus(HIV)-1 infection in adult and pediatric patients 12 years of age and older (and weighing ≥ 35 kg).
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.